Home/Filings/4/0001209191-21-038813
4//SEC Filing

Elstein Amir 4

Accession 0001209191-21-038813

CIK 0000818686other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 7:25 AM ET

Size

7.4 KB

Accession

0001209191-21-038813

Insider Transaction Report

Form 4
Period: 2021-06-05
Elstein Amir
Director
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2021-06-05+6,0412,030,266 total
  • Exercise/Conversion

    Restricted Share Units

    2021-06-056,0410 total
    Ordinary Shares (6,041 underlying)
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on June 5, 2018 and vested on June 5, 2021.

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001721354

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 7:25 AM ET
Size
7.4 KB